2022
Efficacy and safety of first-line anlotinib-based combinations for advanced non-small cell lung cancer: a three-armed prospective study.
Translational lung cancer research
•Interventional Pulmonologist, Pulmonologist (Lung Specialist)
99 publications
2022
Translational lung cancer research
•2022
The clinical respiratory journal
•2022
Lung cancer (Amsterdam, Netherlands)
•2021
Chest
•2021
Chest
•